Botulinum Toxin Therapy Combined with Rehabilitation for Stroke: A Systematic Review of Effect on Motor Function

Toxins (Basel). 2019 Dec 5;11(12):707. doi: 10.3390/toxins11120707.

Abstract

Aim: The purpose of this study was to examine the effectiveness of botulinum toxin A (BoNT-A) therapy combined with rehabilitation on motor function in post-stroke patients.

Methods: The following sources up to December 31, 2018, were searched from inception for articles in English: Pubmed, Scopus, CINAHL, Embase, PsycINFO, and CENTRAL. Trials using injections of BoNT-A for upper and lower limb rehabilitation were examined. We excluded studies that were not performed for rehabilitation or were not evaluated for motor function.

Results: Twenty-six studies were included. In addition to rehabilitation, nine studies used adjuvant treatment to improve spasticity or improve motor function. In the upper limbs, two of 14 articles indicated that significant improvement in upper limb motor function was observed compared to the control group. In the lower limbs, seven of 14 articles indicated that significant improvement in lower limb motor function was observed compared to the control group.

Conclusions: The effect of combined with rehabilitation is limited after stroke, and there is not sufficient evidence, but results suggest that BoNT-A may help to improve motor function. In future studies, the establishment of optimal rehabilitation and evaluation times of BoNT-A treatment will be necessary for improving motor function and spasticity.

Keywords: botulinum toxin; lower limbs; motor function; rehabilitation; spasticity; stroke; upper limbs.

Publication types

  • Systematic Review

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Lower Extremity / physiology
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / physiopathology
  • Neuromuscular Agents / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Stroke / drug therapy*
  • Stroke / physiopathology
  • Stroke Rehabilitation*
  • Upper Extremity / physiology

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A